home / stock / cnsp / cnsp news


CNSP News and Press, CNS Pharmaceuticals Inc.

Stock Information

Company Name: CNS Pharmaceuticals Inc.
Stock Symbol: CNSP
Market: NASDAQ
Website: cnspharma.com

Menu

Get CNSP Alerts

News, Short Squeeze, Breakout and More Instantly...

CNSP - New Vaccine Gives Brain Cancer Patients Hope of Longer Survival

2026-07-10 10:05:00 ET Traditionally, vaccines have been used as a way to prevent many diseases, such as the childhood vaccines used to prevent measles. However, scientists are now developing therapeutic vaccines that can be given to cancer patients in order to slow or reverse the progressi...

CNSP - Scientists Find Targeting Enzyme That Could Block Brain Metastases

2026-06-24 10:05:00 ET Researchers from King’s College London and McMaster University have made a discovery that could fundamentally change how doctors treat brain cancer. The team identified a molecular pathway that appears critical to cancer’s ability to migrate to the b...

CNSP - WashU Vaccine Could Revolutionize Personalized Glioblastoma Treatment

2026-06-23 10:05:00 ET Researchers at Washington University (WashU) Medicine have conducted a small clinical trial testing a new vaccine against glioblastoma . The formulation was administered to nine patients who had undergone surgery and chemo-radiation therapy to remove their tumors....

CNSP - Study Links TBI to Higher Mortality Risk Due to Brain Cancer

2026-06-12 10:05:00 ET A study conducted by a team at Mass General Brigham has found that people with a history of traumatic brain injury had a higher chance of dying as a result of brain cancer. The findings create an urgency to rethink how TBI cases are handled not just in the im...

CNSP - InvestorNewsBreaks - CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Oversubscribed $22.5 Million Financing and Growth Strategy in Investor Presentation

2026-06-08 13:20:00 ET CNS Pharmaceuticals (NASDAQ: CNSP) announced its participation in a virtual investor segment featuring Chief Financial Officer Steve O’Loughlin, who discussed the company’s recently completed oversubscribed $22.5 million financing. The presentation f...

CNSP - CNS Pharmaceuticals CFO, Steve O'Loughlin, Highlights Company's Recent $22.5M Financing in Virtual Investor "What This Means" Segment

Access the segment here HOUSTON, TX / ACCESS Newswire / June 8, 2026 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) ("CNS" or the "Company"), a biotechnology company focused on building a pipeline of innovative therapies addressing significant unmet medical needs, today announced that it...

CNSP - Pediatric Brain Tumors Spread Faster as Immune Cells Build Enabling Scaffolding

2026-06-04 10:05:00 ET Scientists have identified a potential mechanism through which aggressive pediatric brain tumors called diffuse midline gliomas spread. The researchers found that immune cells within the brain, called microglia, produce proteins called fibronectin that he...

CNSP - Study Finds Many Young Adults Suffer Sexual Problems After Cancer Treatment

2026-05-26 10:05:00 ET A new doctoral study from Sweden’s Karolinska Institutet has found that sexual difficulties are common among young people who have survived cancer treatment . The nature and severity of those difficulties shift considerably based on cancer type and how inte...

CNSP - Study Finds That Errors in Brain Cell Division Could Trigger Cancer

2026-05-22 10:05:00 ET Researchers at the University of Virginia have conducted a study that offers new insights into what happens when there are errors in the process of brain cells dividing to form new cells as the brain is growing. Their findings could open the door to treating ...

CNSP - Study Suggests Testosterone Slows Glioblastoma Progression in Men 

2026-05-14 10:05:00 ET New research funded by the NIH has uncovered a link between androgens in men and brain tumors. The preclinical study found that men with low levels of testosterone tended to have shorter survival times when diagnosed with glioblastoma when compared to those that h...

Next 10